Pure Global AI
ChiCTR2200062813Not yet recruiting

Untitled Trial

Development and application of multimodal adaptive respiratory management system in radiotherapy
The First Affiliated Hospital of Medical School of Zhejiang UniversityPhase 2/3Chinese Clinical Trial Registry
Study focus
Disease/Condition
Breast cancer
Sponsor & location
Primary sponsor
The First Affiliated Hospital of Medical School of Zhejiang University
Funder
Key Research and Development Projects of Zhejiang Provincial Science and Technology Department (2021C03122)
Location
China
Timeline & enrollment
Phase
Phase 2/3
Start date
N/A
End date
Dec 31, 2023
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedMalignant neoplasm: Breast, unspecifiedOther carcinoma in situ of breast
Data source
Registry
Chinese Clinical Trial Registry
Trial ID
ChiCTR2200062813
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for ChiCTR2200062813 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by The First Affiliated Hospital of Medical School of Zhejiang University and is currently Not yet recruiting. The study focuses on Breast cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.